• Return to Headlines

Aveo Pharma Raised $81 Million With IPO, Short Of $98 Million Goal (AVEO)

Written on Sat, 03/13/2010 - 12:20pm
By Chip Brian

3/13/2010- Aveo Pharmaceuticals (NASDAQ:AVEO) raised $81 million with its IPO, short of the $98 million that the company was hoping to raise.
The company sold 9 million shares for $9 per share but had hoped to sell about 7 million shares for $13 to $15 per share.
The cancer therapy developer's lead product candidate is currently in last-stage development as a renal cell cancer treatment.

Keywords: aveo pharmaceuticals finance stock market Business News smartrend

Ticker(s): AVEO

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.